Researchers at DZNE and Charité – Universitätsmedizin Berlin have pioneered a novel treatment for the most common autoimmune encephalitis.
Researchers at DZNE and Charité – Universitätsmedizin Berlin have pioneered a novel treatment for the most common autoimmune encephalitis.